Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-P Tony

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Scandinavian Journal of Rheumatology|August 17, 2017
Simple screening tools predict death and cardiovascular events in patients with rheumatic diseaseM Breunig, S Kleinert, S Lehmann, et al.
Zeitschrift Fur Rheumatologie|May 25, 2017
[Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)]J C Henes, H Schulze-Koops, M Witt, et al.
Scandinavian Journal of Rheumatology|July 18, 2019
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritisF Behrens, M Koehm, E C Schwaneck, et al.
Rheumatology International|January 1, 1997
Endothelial cells are the major source of sICAM-1 in rheumatoid synovial tissueV Krenn, J Schedel, A Döring, et al.
Annals of the Rheumatic Diseases|February 27, 2010
Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseasesS Kleinert, O Kurzai, J Elias, et al.
Arthritis and Rheumatism|September 10, 2011
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trialW Rigby, H-P Tony, K Oelke, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditionsS Kleinert, H-P Tony, K Krueger, et al.
Zeitschrift Fur Rheumatologie|February 24, 2019
Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jawE C Schwaneck, A Streit, M Krone, et al.
Zeitschrift Fur Rheumatologie|October 3, 2018
Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in GermanyA Krause, P M Aries, S Berger, et al.
Annals of the Rheumatic Diseases|April 12, 2006
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trialJ Braun, J Zochling, X Baraliakos, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Scandinavian Journal of Rheumatology|August 17, 2017
Simple screening tools predict death and cardiovascular events in patients with rheumatic diseaseM Breunig, S Kleinert, S Lehmann, et al.
Zeitschrift Fur Rheumatologie|May 25, 2017
[Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)]J C Henes, H Schulze-Koops, M Witt, et al.
Scandinavian Journal of Rheumatology|July 18, 2019
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritisF Behrens, M Koehm, E C Schwaneck, et al.
Rheumatology International|January 1, 1997
Endothelial cells are the major source of sICAM-1 in rheumatoid synovial tissueV Krenn, J Schedel, A Döring, et al.
Annals of the Rheumatic Diseases|February 27, 2010
Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseasesS Kleinert, O Kurzai, J Elias, et al.
Arthritis and Rheumatism|September 10, 2011
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trialW Rigby, H-P Tony, K Oelke, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditionsS Kleinert, H-P Tony, K Krueger, et al.
Zeitschrift Fur Rheumatologie|February 24, 2019
Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jawE C Schwaneck, A Streit, M Krone, et al.
Zeitschrift Fur Rheumatologie|October 3, 2018
Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in GermanyA Krause, P M Aries, S Berger, et al.
Annals of the Rheumatic Diseases|April 12, 2006
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trialJ Braun, J Zochling, X Baraliakos, et al.
Pageof 9